3-Bromo-4-fluorotoluene

We are 3-Bromo-4-fluorotoluene CAS:452-62-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Name: 3-Bromo-4-fluorotoluene
Other Name: 2-Bromo-1-fluoro-4-methylbenzene;1-Bromo-2-fluoro-5-methylbenzene;5-Methyl-2-fluorobromobenzene
CAS No: 452-62-0
MF: C7H6BrF
MW: 189.02500
Density: 1.507 g/mL at 25 °C(lit.)
Boiling point: 169 °C756 mm Hg(lit.)
Flash point: 164 °F
Refractive index: n20/D 1.531(lit.)
Vapor Pressure: 2.07mmHg at 25°C
UN Number: UN2811
UN Proper Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Transport hazard class: 6.1
Packing group: III
 
Specification
Appearance: Colorless to pale yellow liquid
Purity: ≥98%
Water: ≤0.5%
 
Application: Pharmaceutical intermediates, agrochemical intermediates, OLED intermediates.
Package: 25kg/drum, packed in plastic drum or plastic coated iron drum.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

3-Bromo-4-fluorotoluene


Related News: This part is mainly anti-tumor drugs, prostate drugs and certain hormone drugs.(1R,2R)-N,N'-Dimethyl-1,2-cyclohexanediamine Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,” said Mark Corbett, EVP, Inceptua Medicines Access.39562-25-9 Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,” said Mark Corbett, EVP, Inceptua Medicines Access.2,6-dicloropurina CAS:5451-40-1 Developing countries such as China and India have good foundations for undertaking global industrial transfers because of their comparative advantages. With the continuous improvement of China’s fine chemical technology level, the types of products and market shares in China’s undertaking industrial transfer have gradually increased.An analysis of the top 20 global companies by R&D spend for 2018 shows that companies with expensive late-stage pipeline drugs are spending significant proportions of their annual revenue on R&D.

Related Products
Product Name
Ethyl(ethoxymethylene)cyanoacetate View Details
n-Butyl vinyl ether View Details
4-(Trans-4-pentylcyclohexyl) phenyl boronic acid View Details
L-Serine manufacturer O-ethylhydroxylamine,hydrochloride manufacturer [4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methanol manufacturer 2-Aminoperimidine hydrochloride manufacturer N-(3-chloropropyl)dibutylamine manufacturer